These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38649650)

  • 1. Cardiovascular screening outcomes in the Dutch survivorship care program for Hodgkin lymphoma survivors.
    Lammers EMJ; Nijdam A; Zijlstra JM; Janus CPM; de Weijer RJ; Appelman Y; Manintveld OC; Teske AJ; van Leeuwen FE; Aleman BMP
    J Cancer Surviv; 2024 Apr; ():. PubMed ID: 38649650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and Cost-Effectiveness of Survivorship Care for Survivors of Hodgkin Lymphoma (INSIGHT Study): Protocol for a Multicenter Retrospective Cohort Study With a Quasi-Experimental Design.
    Lammers EMJ; Zijlstra JM; Retèl VP; Aleman BMP; van Leeuwen FE; Nijdam A;
    JMIR Res Protoc; 2024 Apr; 13():e55601. PubMed ID: 38635308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer and cardiovascular outcomes after breast cancer in survivors of Hodgkin lymphoma.
    Krul IM; Boekel NB; Kramer I; Janus CPM; Krol ADG; Nijziel MR; Zijlstra JM; van der Maazen RWM; Roesink JM; Jacobse JN; Schaapveld M; Schmidt MK; Opstal-van Winden AWJ; Sonke GS; Russell NS; Aleman BMP; van Leeuwen FE
    Cancer; 2022 Dec; 128(24):4285-4295. PubMed ID: 36281718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and design of a cohort study on primary ovarian insufficiency in female survivors of Hodgkin's lymphoma: influence on long-term adverse effects (SOPHIA).
    Krul IM; Opstal-van Winden AWJ; Zijlstra JM; Appelman Y; Schagen SB; Meijboom LJ; Serné E; Lambalk CB; Lips P; van Dulmen-den Broeder E; Hauptmann M; Daniëls LA; Aleman BMP; van Leeuwen FE
    BMJ Open; 2018 Sep; 8(9):e018120. PubMed ID: 30206072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late Cardiological Sequelae and Long-Term Monitoring in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi.
    Oliva S; Puzzovivo A; Gerardi C; Allocati E; De Sanctis V; Minoia C; Skrypets T; Guarini A; Gini G
    Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The BETER survivorship care initiative for Hodgkin lymphoma; tailored survivorship care for late effects of treatment].
    Dekker N; van 't Veer MB; Aleman BM; van Leeuwen FE; Raemaekers JM
    Ned Tijdschr Geneeskd; 2015; 159():A9269. PubMed ID: 26577382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-Reported Survivorship Care Practices and Late Effects After Treatment of Hodgkin and Non-Hodgkin Lymphoma.
    Frick MA; Vachani CC; Hampshire MK; Bach C; Arnold-Korzeniowski K; Metz JM; Hill-Kayser CE
    JCO Clin Cancer Inform; 2018 Dec; 2():1-10. PubMed ID: 30652594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of recommended posttreatment services for adolescent and young adult survivors of Hodgkin lymphoma.
    Hahn EE; Wu YL; Munoz-Plaza CE; Garcia Delgadillo J; Cooper RM; Chao CR
    Cancer; 2019 May; 125(9):1558-1567. PubMed ID: 30620388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High risk of cardiovascular side effects after treatment of Hodgkin's lymphoma - is there a need for intervention in long-term survivors?
    Andersson A; Enblad G; Erlanson M; Johansson AS; Molin D; Tavelin B; Näslund U; Melin B
    Ups J Med Sci; 2021; 126():. PubMed ID: 33889307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Subclinical Cardiovascular Disease by Cardiovascular Magnetic Resonance in Lymphoma Survivors.
    van der Velde N; Janus CPM; Bowen DJ; Hassing HC; Kardys I; van Leeuwen FE; So-Osman C; Nout RA; Manintveld OC; Hirsch A
    JACC CardioOncol; 2021 Dec; 3(5):695-706. PubMed ID: 34988478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of cardiovascular counseling and screening in Hodgkin lymphoma survivors.
    Daniëls LA; Krol SD; de Graaf MA; Scholte AJ; van 't Veer MB; Putter H; de Roos A; Schalij MJ; van de Poll-Franse LV; Creutzberg CL
    Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):164-71. PubMed ID: 25195991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure is associated with occult cardiovascular disease in prospectively studied Hodgkin lymphoma survivors after chest radiation.
    Chen MH; Blackington LH; Zhou J; Chu TF; Gauvreau K; Marcus KJ; Fisher DC; Diller LR; Ng AK
    Leuk Lymphoma; 2014 Nov; 55(11):2477-83. PubMed ID: 24397615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot randomized controlled trial of an online intervention for Hodgkin lymphoma survivors to increase knowledge about late effects and recommended screening.
    Rick TJ; Sagaram S; Jewett PI; Lee HY; Sadak KT; Turcotte LM; Vogel RI; Blaes A
    J Cancer Surviv; 2024 Apr; ():. PubMed ID: 38642203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for coronary artery disease after mediastinal irradiation in Hodgkin lymphoma survivors: phase II study of indication and acceptance†.
    Daniëls LA; Krol AD; de Graaf MA; Scholte AJ; Van't Veer MB; Putter H; de Roos A; Schalij MJ; Creutzberg CL
    Ann Oncol; 2014 Jun; 25(6):1198-203. PubMed ID: 24692582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproductive ability in survivors of childhood, adolescent, and young adult Hodgkin lymphoma: a review.
    Drechsel KCE; Pilon MCF; Stoutjesdijk F; Meivis S; Schoonmade LJ; Wallace WHB; van Dulmen-den Broeder E; Beishuizen A; Kaspers GJL; Broer SL; Veening MA
    Hum Reprod Update; 2023 Jul; 29(4):486-517. PubMed ID: 36779325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time--a population-based comparative study.
    Glimelius I; Ekberg S; Linderoth J; Jerkeman M; Chang ET; Neovius M; Smedby KE
    J Cancer Surviv; 2015 Dec; 9(4):599-609. PubMed ID: 25689964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Care Utilization and Cardiovascular Screening in Adult Survivors of Childhood Cancer.
    Ohlsen TJD; Chen Y; Baldwin LM; Hudson MM; Nathan PC; Snyder C; Syrjala KL; Tonorezos ES; Yasui Y; Armstrong GT; Oeffinger KC; Chow EJ
    JAMA Netw Open; 2023 Dec; 6(12):e2347449. PubMed ID: 38091040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes in Hodgkin lymphoma survivors. Temporary trends and comparison with general population.
    Núñez-García B; Clemente MB; Sánchez JC; Royuela A; Ibargüen BCS; Méndez M; López-Ibor JV; Martínez M; Traseira C; Garitaonaindia Y; Aguado R; Calvo V; Torrente M; Parejo C; Provencio Z; Provencio M
    Hematol Oncol; 2023 Aug; 41(3):407-414. PubMed ID: 36934306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers to long-term follow-up in pediatric Hodgkin lymphoma survivors.
    Tinsley H; Gramatges M; Dreyer Z; Okcu MF; Shakeel O
    Pediatr Blood Cancer; 2024 Apr; 71(4):e30855. PubMed ID: 38200619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Preventive Care of Hematopoietic Stem Cell Transplantation Survivors: Time to Educate and Empower Recipients and Providers.
    Fulcher J; Blanchard AP; Bredeson C; van Walraven C
    Transplant Cell Ther; 2023 Feb; 29(2):131.e1-131.e6. PubMed ID: 36336256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.